Resource Category
Articles and Publications

Unobserved versus observed office buprenorphine/naloxone induction: A pilot randomized clinical trial

Posted 10/23/2020 (updated 4/3/2024)

These pilot study results suggest comparable safety and effectiveness of unobserved and office induction and point toward utilization of non-inferiority design during future definitive protocol development. By addressing an important barrier for physician adoption, further validation of the unobserved buprenorphine induction method will hopefully lead to increased availability of effective opioid dependence treatment.